D

Defence Therapeutics
DTC

Latest price

Financial Snapshot

gainify

Market Data

Market Cap
CA$48.71M
EV
CA$49.86M
Shares Outstanding
56.19M
Beta
1.40

Wall Street View

Analyst Rating
NOT_AVAILABLE
Analyst Target Price
-
P/E undefinedE
-
P/Revenue undefinedE
-

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Defence Therapeutics Inc.

gainify

D

Defence Therapeutics Inc.

DTC

Defence Therapeutics Inc. develops a biological drug enhancer platform that improves the efficacy and safety of a multitude of a multitude of biological/biosimilar based pharmaceuticals used in the treatment of cancer and infectious diseases. The company focuses on th...

Sector

Healthcare

Industry

Biotechnology

CEO

Plouffe, Sebastien

Employees

IPO Date

2021-05-10

Headquarters

1680 – 200 Burrard Street, Vancouver, British Columbia, V6C 3L6, Canada

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved